Received: from AS8PR02MB7014.eurprd02.prod.outlook.com (2603:10a6:20b:2ec::23) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Thu, 25 Jun 2026 10:39:51 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by AS8PR02MB7014.eurprd02.prod.outlook.com (2603:10a6:20b:2ec::23) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.139.19; Thu, 25 Jun 2026 10:39:50 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%2]) with mapi id 15.21.0159.015; Thu, 25 Jun 2026 10:39:50 +0000 From: "Andrus Varki - RA" To: "Info - SOM" Cc: =?utf-8?Q?K=C3=A4rolin_Jenas_-_RA?= References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: Subject: =?utf-8?Q?Ed:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Thu, 25 Jun 2026 13:39:50 +0300 Keywords: ly Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0072_01DD04DF.B0737E40" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wEidV1AAvAO1mEBgZBMcAI+CNbTAO+NVD0CDMzEsQ== Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 25 Jun 2026 10:39:50.6689 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 2f834595-8be3-4b8b-8cde-08ded2a615c7 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GVXPR02MB12202:EE_|AS8PR02MB7014:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 2f834595-8be3-4b8b-8cde-08ded2a615c7 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|23010399003|366016|31052699007|39142699007|8096899003|55112099003|13003099007|56012099006|22082099003|18002099003|11063799006|4143699003|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(23010399003)(366016)(31052699007)(39142699007)(8096899003)(55112099003)(13003099007)(56012099006)(22082099003)(18002099003)(11063799006)(4143699003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 25 Jun 2026 10:39:50.4722 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 2f834595-8be3-4b8b-8cde-08ded2a615c7 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS8PR02MB7014 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.1658951 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0159.007 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.7 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:318::18 X-OlkEid: 0000000033F4068251E5764083FB7241D8AC8008070034AD76187591974DBF6C4F76951C873A0100020000000000EE036A86AA193F47AA713E32FE8F2E5700000000123800009C3D4C1F7179FF4982BF8F3132D9147C X-MS-Has-Attach: X-MS-TNEF-Correlator: X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-25T10:39:49.990Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; acceptlanguage: et-EE, en-US x-codetwo-clientsignature-inserted: true X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: q7OKuVoRpw50D2hrZ6JclS1TelI4zCqsELZSO+cBUcN4WYf7/iVFIYHzFDMKzkHpCAMAwYi+NHDqiQNrftqIN39Ahr2HMXL27/a8//SgcZE= This is a multipart message in MIME format. ------=_NextPart_000_0072_01DD04DF.B0737E40 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie:    26.05.2026 nr 1.2-3/1355-1 Meie:   25.06.2026 nr JUR-3/3200-2 Tere Ravimiametil ei ole märkuseid eelnõule. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0072_01DD04DF.B0737E40 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Teie:=E2=80=82=E2=80=82=E2=80=82=E2=80=8226.05.2026 nr = 1.2-3/1355-1
Meie:=E2=80=82=E2=80=82=E2=80=8225.06.2026 nr JUR-3/3200-2


Tere

Ravimiametil ei ole m=C3=A4rkuseid eeln=C3=B5ule.



Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles = e-kirjas sisalduv teave (kaasa arvatud manused) on m=C3=B5eldud = ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja = adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=C3=A4ljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



 

------=_NextPart_000_0072_01DD04DF.B0737E40--